These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 1313738)

  • 41. Effect of antineoplastic agents on the DNA cleavage/religation reaction of eukaryotic topoisomerase II: inhibition of DNA religation by etoposide.
    Osheroff N
    Biochemistry; 1989 Jul; 28(15):6157-60. PubMed ID: 2551366
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thioguanine substitution alters DNA cleavage mediated by topoisomerase II.
    Krynetskaia NF; Cai X; Nitiss JL; Krynetski EY; Relling MV
    FASEB J; 2000 Nov; 14(14):2339-44. PubMed ID: 11053256
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Linkage of a triple helix-forming oligonucleotide to amsacrine-4-carboxamide derivatives modulates the sequence-selectivity of topoisomerase II-mediated DNA cleavage.
    Arimondo P; Bailly C; Boutorine A; Asseline U; Sun JS; Garestier T; Hélène C
    Nucleosides Nucleotides Nucleic Acids; 2000 Aug; 19(8):1205-18. PubMed ID: 11097051
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Topoisomerase II.etoposide interactions direct the formation of drug-induced enzyme-DNA cleavage complexes.
    Burden DA; Kingma PS; Froelich-Ammon SJ; Bjornsti MA; Patchan MW; Thompson RB; Osheroff N
    J Biol Chem; 1996 Nov; 271(46):29238-44. PubMed ID: 8910583
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mode of action of topoisomerase II-targeting agents at a specific DNA sequence. Uncoupling the DNA binding, cleavage and religation events.
    Sørensen BS; Sinding J; Andersen AH; Alsner J; Jensen PB; Westergaard O
    J Mol Biol; 1992 Dec; 228(3):778-86. PubMed ID: 1335085
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The interaction between nuclear topoisomerase II activity from human leukemia cells, exogenous DNA, and 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) or 4-(4,6-O-ethylidene-beta-D-glucopyranoside) (VP-16) indicates the sensitivity of the cells to the drugs.
    Estey EH; Silberman L; Beran M; Andersson BS; Zwelling LA
    Biochem Biophys Res Commun; 1987 Apr; 144(2):787-93. PubMed ID: 3034264
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protein kinase C phosphorylates topoisomerase II: topoisomerase activation and its possible role in phorbol ester-induced differentiation of HL-60 cells.
    Sahyoun N; Wolf M; Besterman J; Hsieh T; Sander M; LeVine H; Chang KJ; Cuatrecasas P
    Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1603-7. PubMed ID: 3006058
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orobol.
    Yamashita Y; Kawada S; Nakano H
    Biochem Pharmacol; 1990 Feb; 39(4):737-44. PubMed ID: 2154993
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of quinolone derivatives on eukaryotic topoisomerase II. A novel mechanism for enhancement of enzyme-mediated DNA cleavage.
    Robinson MJ; Martin BA; Gootz TD; McGuirk PR; Moynihan M; Sutcliffe JA; Osheroff N
    J Biol Chem; 1991 Aug; 266(22):14585-92. PubMed ID: 1650363
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aurintricarboxylic acid, a putative inhibitor of apoptosis, is a potent inhibitor of DNA topoisomerase II in vitro and in Chinese hamster fibrosarcoma cells.
    Benchokroun Y; Couprie J; Larsen AK
    Biochem Pharmacol; 1995 Jan; 49(3):305-13. PubMed ID: 7857317
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ectopic expression of inactive forms of yeast DNA topoisomerase II confers resistance to the anti-tumour drug, etoposide.
    Vassetzky YS; Alghisi GC; Roberts E; Gasser SM
    Br J Cancer; 1996 May; 73(10):1201-9. PubMed ID: 8630279
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of the DNA topoisomerase-II-mediated cleavage of the long terminal repeat of Drosophila 1731 retrotransposon.
    Nahon E; Best-Belpomme M; Saucier JM
    Eur J Biochem; 1993 Nov; 218(1):95-102. PubMed ID: 8243480
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A drug-resistant variant of topoisomerase II alpha in human HL-60 cells exhibits alterations in catalytic pH optimum, DNA binding and sub-nuclear distribution.
    Boege F; Kjeldsen E; Gieseler F; Alsner J; Biersack H
    Eur J Biochem; 1993 Dec; 218(2):575-84. PubMed ID: 8269948
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exploiting mechanistic differences between drug classes to define functional drug interaction domains on topoisomerase II. Evidence that several diverse DNA cleavage-enhancing agents share a common site of action on the enzyme.
    Corbett AH; Hong D; Osheroff N
    J Biol Chem; 1993 Jul; 268(19):14394-8. PubMed ID: 8390992
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of mammalian DNA topoisomerase I and II mediated DNA cleavage by saintopin, a new antitumor agent from fungus.
    Yamashita Y; Kawada S; Fujii N; Nakano H
    Biochemistry; 1991 Jun; 30(24):5838-45. PubMed ID: 1646001
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mitogen-induced topoisomerase II synthesis precedes DNA synthesis in human breast cancer cells.
    Epstein RJ; Smith PJ
    Biochem Biophys Res Commun; 1989 Apr; 160(1):12-7. PubMed ID: 2540740
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The efficacy of topoisomerase II-targeted anticancer agents reflects the persistence of drug-induced cleavage complexes in cells.
    Bandele OJ; Osheroff N
    Biochemistry; 2008 Nov; 47(45):11900-8. PubMed ID: 18922022
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The top2-5 mutant of yeast topoisomerase II encodes an enzyme resistant to etoposide and amsacrine.
    Jannatipour M; Liu YX; Nitiss JL
    J Biol Chem; 1993 Sep; 268(25):18586-92. PubMed ID: 8395511
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cell cycle stage dependent variations in drug-induced topoisomerase II mediated DNA cleavage and cytotoxicity.
    Estey E; Adlakha RC; Hittelman WN; Zwelling LA
    Biochemistry; 1987 Jul; 26(14):4338-44. PubMed ID: 2822085
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phosphorylation of serine 1106 in the catalytic domain of topoisomerase II alpha regulates enzymatic activity and drug sensitivity.
    Chikamori K; Grabowski DR; Kinter M; Willard BB; Yadav S; Aebersold RH; Bukowski RM; Hickson ID; Andersen AH; Ganapathi R; Ganapathi MK
    J Biol Chem; 2003 Apr; 278(15):12696-702. PubMed ID: 12569090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.